Question-filled future for dose-escalation in prostate cancer

被引：0
|
作者：
机构：
来源：
Int J Radiat Oncol Biol Phys | / 3卷 / 891期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer
    Pollack, A
    Zagars, GK
    Smith, LG
    Lee, JJ
    von Eschenbach, AC
    Antolak, JA
    Starkschall, G
    Rosen, I
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) : 3904 - 3911
  • [32] Phase I dose-escalation study of the safety and pharmacokinetics of atrasentan: An endothelin receptor antagonist for refractory prostate cancer
    Zonnenberg, BA
    Groenewegen, G
    Janus, TJ
    Leahy, TW
    Humerickhouse, RA
    Isaacson, JD
    Carr, RA
    Voest, E
    CLINICAL CANCER RESEARCH, 2003, 9 (08) : 2965 - 2972
  • [33] A phase I/II dose-escalation study of exisulind and docetaxel in patients with hormone-refractory prostate cancer
    Ryan, CW
    Stadler, WM
    Vogelzang, NJ
    BJU INTERNATIONAL, 2005, 95 (07) : 963 - 968
  • [34] The Canadian dose-escalation prophylaxis study
    Feldman, B
    HAEMOPHILIA, 2000, 6 : 18 - 19
  • [35] Dose escalation for prostate cancer: Which dose for which person?
    Sandler, HM
    CONTROVERSIES IN URO-ONCOLOGY, 2002, 36 : 10 - 15
  • [36] A comparative dose-escalation analysis for reirradiated cancer patients with and without appropriate dose mapping
    Biplab Sarkar
    Subhra Snigdha Biswal
    Tanweer Shahid
    Karthik Appunu
    Jibak Bhattacharya
    Tharmarnadar Ganesh
    Anusheel Munshi
    Anindita Das
    Radiation and Environmental Biophysics, 2024, 63 : 71 - 80
  • [37] A Dose-Escalation Study for High-Dose-Rate Brachytherapy Boost in Intermediate- and High-Risk Prostate Cancer Patients
    Chiorda, B. Noris
    Blanchard, P.
    Calmels, L.
    Patard, J. J.
    Baumert, H.
    Moussier, A.
    Fizazi, K.
    Champoudry, J.
    Bossi, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E238 - E239
  • [38] A comparative dose-escalation analysis for reirradiated cancer patients with and without appropriate dose mapping
    Sarkar, Biplab
    Biswal, Subhra Snigdha
    Shahid, Tanweer
    Appunu, Karthik
    Bhattacharya, Jibak
    Ganesh, Tharmarnadar
    Munshi, Anusheel
    Das, Anindita
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2024, 63 (01) : 71 - 80
  • [39] SHOULD ELDERLY CANCER-PATIENTS BE ENTERED IN DOSE-ESCALATION STUDIES
    MONFARDINI, S
    SORIO, R
    KAYE, S
    ANNALS OF ONCOLOGY, 1994, 5 (10) : 964 - 965
  • [40] Randomized dose-escalation designs for drug combination cancer trials with immunotherapy
    Mozgunov, Pavel
    Jaki, Thomas
    Paoletti, Xavier
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2019, 29 (02) : 359 - 377
12345